From August 28, 2015 to September 30, 2015, the company has repurchased 58,729 shares, representing 0.46% for KRW 1,272.37 million. With this, the company has completed the repurchase of 58,729 shares, representing 0.46% for KRW 1,272.37 million under the buyback announced on August 28, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,670 KRW | -1.57% | -5.58% | -9.35% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-9.35% | 121M | |
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+20.07% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.6B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on August 28, 2015.